These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1635 related articles for article (PubMed ID: 33843442)

  • 1. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of stimulator of interferon genes (STING) expression and CD8
    Fukai S; Nakajima S; Saito M; Saito K; Kase K; Nakano H; Sato T; Sakuma M; Kaneta A; Okayama H; Mimura K; Sakamoto W; Saze Z; Momma T; Kono K
    Gastric Cancer; 2023 Nov; 26(6):878-890. PubMed ID: 37542528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    He XU; Yu Y; Zhang X; Gao C; Wang H; Liu C
    Cancer Genomics Proteomics; 2023; 20(5):476-486. PubMed ID: 37643778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 13. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO.
    Wen S; Peng W; Chen Y; Du X; Xia J; Shen B; Zhou G
    BMC Cancer; 2022 Feb; 22(1):193. PubMed ID: 35184748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cytoplasmic DNA-Sensing cGAS-STING pathway-mediated gene signatures and molecular subtypes in prostate cancer.
    Yang J; Xu Z; Zheng W; Li Y; Wei Q; Yang L
    BMC Cancer; 2024 Jun; 24(1):732. PubMed ID: 38877472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
    Li J; Li X; Zhang C; Zhang C; Wang H
    Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.